Indiana University School of Medicine Infectious Disease

Topics

• HIV/AIDS Research and Interventions 141
• Cervical Cancer and HPV Research 129
• Syphilis Diagnosis and Treatment 86
• Reproductive tract infections research 65
• HIV-related health complications and treatments 62
• Clostridium difficile and Clostridium perfringens research 58
• Malaria Research and Control 53
• HIV/AIDS drug development and treatment 46
• Neonatal and Maternal Infections 39
• Fungal Infections and Studies 28
• Tuberculosis Research and Epidemiology 21
• Streptococcal Infections and Treatments 19

Most cited

1. Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial.

   Lancet (London, England) · 2026 · 31 citations · Teresa Batteiger

2. 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Histoplasmosis: Treatment of Asymptomatic Histoplasma Pulmonary Nodules (Histoplasmomas) and Mild or Moderate Acute Pulmonary Histoplasmosis in Adults, Children, and Pregnant People.

   Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026 · 18 citations · Satish Mocherla

3. Association of Intensive Care Unit Patient Load and Demand With Mortality Rates in US Department of Veterans Affairs Hospitals During the COVID-19 Pandemic.

   JAMA network open · 2021 · 230 citations · Andrew Dysangco

4. Group B streptococcal infections in pregnancy and early life.

   Clinical microbiology reviews · 2025 · 31 citations · David Aronoff

5. Lenacapavir administered every 26 weeks or daily in combination with oral daily antiretroviral therapy for initial treatment of HIV: a randomised, open-label, active-controlled, phase 2 trial.

   The lancet. HIV · 2023 · 98 citations · Samir Gupta

6. Lenacapavir treatment-emergent HIV-1 capsid resistance mutations are frequently associated with replication defects.